Jianjian Zheng
11PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Sep 25, 2025
Screening Based on Structural and Biological Verification of Stachyose as a PPARγ-Modulating Ligand for the Treatment of Non-Alcoholic Fatty Liver Disease.Binbo Fang, Mengyuan Li, Feng Jiang
|Oct 03, 2024
ATF3-mediated transactivation of CXCL14 in HSCs during liver fibrosis.Xinmiao Li, Lifan Lin, Yifei Li
|Aug 08, 2024
The IGF2BP3/Notch/Jag1 pathway: A key regulator of hepatic stellate cell ferroptosis in liver fibrosis.Xinmiao Li, Yifei Li, Weizhi Zhang
|Mar 04, 2024
LncRNA-SNHG5 mediates activation of hepatic stellate cells by regulating NF2 and Hippo pathway.Rongrong Zhang, Yating Zhan, Zhichao Lang
|Jan 19, 2024
Circular RNA cVIM promotes hepatic stellate cell activation in liver fibrosis via miR-122-5p/miR-9-5p-mediated TGF-β signaling cascade.Zhenxu Zhou, Rongrong Zhang, Xinmiao Li
|Jan 03, 2024
Author Correction: LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition.Yating Zhan, Qiqi Tao, Qishan Meng
Pageof 2
